Get started
Genmab A/S 6.25% 15-DEC-2032Genmab A/S 6.25% 15-DEC-2032Genmab A/S 6.25% 15-DEC-2032

Genmab A/S 6.25% 15-DEC-2032

OverviewAnalysis

Chart


Full chart

Key terms


Outstanding amount
‪1.50 B‬ USD
Face value
1,000.00 USD
Minimum denomination
200,000.00 USD
Coupon
6.25% (Fixed)
Coupon frequency
Semi-annual
Maturity date
Dec 15, 2032
Term to maturity
6 years

About Genmab A/S 6.25% 15-DEC-2032


Issuer
Genmab A/S
Sector
Health Technology
Industry
Pharmaceuticals: Major
Home page
genmab.com
Issue date
Dec 3, 2025
Identifiers
3
ISINUSK3968JAA80
Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease, and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998, and is headquartered in Copenhagen, Denmark.

See how Genmab A/S is moving with its highest-yielding bonds.

Analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.